Product Overview

Tesamorelin is a synthetic peptide analogue of Growth Hormone‑Releasing Hormone (GHRH) designed to mimic the natural GHRH hormone’s activity in scientific research models. Unlike some shorter GHRH analogues, Tesamorelin includes the full active sequence (amino acids 1–44) with modifications that enhance its stability and receptor interaction in experimental settings.

In research contexts, Tesamorelin is used to investigate mechanisms of endocrine regulation, growth hormone secretion pathways, and receptor pharmacology by stimulating the release of endogenous growth hormone (GH) via the GHRH receptor. It is supplied as a high‑purity peptide for controlled laboratory studies and not intended for clinical or therapeutic use.

Mechanism of Action (Research Context)

Tesamorelin activates the GHRH receptor on somatotroph cells of the anterior pituitary gland in experimental models, thereby initiating intracellular signaling cascades that lead to secretion of endogenous growth hormone (GH). This mechanism allows scientists to explore:

• Growth hormone release dynamics
• Pituitary–hypothalamic endocrine signaling
• GHRH receptor binding and pharmacological profiling
• Downstream anabolic and metabolic pathways triggered by GH signaling

Because it incorporates the full active sequence of native GHRH and peptide modifications, Tesamorelin often provides a broader and more potent receptor activation profile compared with truncated analogues in experimental systems.

Key Features & Scientific Highlights

📌 Full‑Length GHRH Analogue: Combines the active amino‑terminal GHRH sequence (1–44) with stability enhancements for research use.
📌 Growth Hormone Secretagogue: Studied for its ability to stimulate GH release via GHRH‑receptor activation.
📌 High‑Purity Peptide: Supplied as lyophilized peptide suitable for reconstitution and laboratory experimentation.
📌 Used in Endocrine Research: Enables investigation of neuroendocrine signaling, pituitary function, and hormone release dynamics.

Research Applications

Scientists and researchers may use Tesamorelin 10 mg peptide in controlled laboratory studies to investigate:

🔬 GHRH and GH axis signaling — how Tesamorelin analogues interact with receptors and stimulate hormone release.
🔬 Endocrine regulatory pathways — studying feedback control between hypothalamus and pituitary.
🔬 Molecular pharmacology — receptor binding and downstream signaling dynamics.
🔬 Comparative peptide analysis — testing differences between full‑length and truncated peptide analogues.

These applications help expand understanding of neuroendocrine regulation and hormonal pathways in biological research.

Chemical & Biological Profile

• Name: Tesamorelin
• Peptide Class: GHRH analogue (1–44)
• Mechanism: Binds and activates the Growth Hormone‑Releasing Hormone receptor
• Form: Lyophilized white powder
• Purity: High purity (typically ≥ 98%), suitable for laboratory research
• Functional Focus: Endocrine signaling and GH release pathways

Usage & Safety Notice

✅ This product is strictly for research and laboratory use only.
❗ It is not intended for human or veterinary therapeutic use, clinical treatment, or ingestion.
⚠️ Always follow proper laboratory procedures, peptide handling protocols, and safety guidelines when working with this compound.

Sources & Verification

This description is based on publicly available scientific literature and peptide supplier information, including endocrine physiology overviews and established peptide research sources.